Accessibility Menu
Alpha Tau Medical logo

Alpha Tau Medical

(NASDAQ) DRTS

Current Price$9.39
Market Cap$905.62M
Since IPO (2021)+2%
5 Year-3%
1 Year+233%
1 Month+23%

Alpha Tau Medical Financials at a Glance

Market Cap

$905.62M

Revenue (TTM)

$0.00

Net Income (TTM)

-$56.88M

EPS (TTM)

-$0.66

P/E Ratio

-15.58

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$9.39

Volume

1,390,932.878

Open

$10.27

Previous Close

$9.35

Daily Range

$9.13 - $10.29

52-Week Range

$2.82 - $11.62

Estimated Earnings Date

Aug 10, 2026

DRTS: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alpha Tau Medical

Industry

Healthcare Equipment and Supplies

Employees

112

CEO

Uzi Sofer, MBA

Headquarters

Jerusalem, 9777605, IL

DRTS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-91%

Return on Capital

-47%

Return on Assets

-52%

Earnings Yield

-6.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$905.62M

Shares Outstanding

88.01M

Volume

1.39M

Avg. Volume

625.76K

Financials (TTM)

Gross Profit

-$1.23M

Operating Income

-$42.29M

EBITDA

-$41.06M

Operating Cash Flow

-$26.68M

Capital Expenditure

-$6.08M

Free Cash Flow

-$32.76M

Cash & ST Invst.

$76.90M

Total Debt

$13.73M

Alpha Tau Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$905.62M

N/A

Market Cap/Employee

$7.24M

N/A

Employees

125

N/A

Net Income

-$22.94M

-163.9%

EBITDA

-$13.31M

-43.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$65.89M

+67.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$13.14M

+16.4%

Short Term Debt

$1.20M

+20.0%

Return on Assets

-52.29%

N/A

Return on Invested Capital

-47.08%

N/A

Free Cash Flow

-$32.76M

N/A

Operating Cash Flow

-$26.68M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANROAlto Neuroscience, Inc.
$18.26-8.84%
CADLCandel Therapeutics, Inc.
$8.51-8.20%
DBVTDBV Technologies S.A.
$16.59-5.63%
CLLSCellectis S.A.
$3.06-0.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%

Questions About DRTS

What is the current price of Alpha Tau Medical?

Alpha Tau Medical is trading at $9.35 per share.

What is the 52-week range for Alpha Tau Medical?

Over the past 52 weeks, Alpha Tau Medical has traded between $2.82 and $11.62.

How much debt does Alpha Tau Medical have?

As of the most recent reporting period, Alpha Tau Medical reported total debt of $14.34M.

How much cash does Alpha Tau Medical have on hand?

Alpha Tau Medical reported $8.44M in cash and cash equivalents in its most recent financial results.

What is Alpha Tau Medical’s dividend yield?

Alpha Tau Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.